awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42392542-D11E75E2-084B-457C-B0BA-7772AFB43C5F
Q42392542-D11E75E2-084B-457C-B0BA-7772AFB43C5F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42392542-D11E75E2-084B-457C-B0BA-7772AFB43C5F
Comment on 'costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib'.
P2860
Q42392542-D11E75E2-084B-457C-B0BA-7772AFB43C5F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42392542-D11E75E2-084B-457C-B0BA-7772AFB43C5F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47b82afcece89f45b469eade30197a37872bcfdc
P2860
Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial.